These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

806 related items for PubMed ID: 34257548

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes.
    Miyazawa T, Marushima H, Saji H, Kojima K, Hoshikawa M, Takagi M, Nakamura H.
    Ann Thorac Cardiovasc Surg; 2019 Feb 20; 25(1):1-9. PubMed ID: 30282880
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients.
    Li W, Song P, Guo L, Liu X, Guo C, Ying J, Gao S.
    Thorac Cancer; 2019 Feb 20; 10(2):175-182. PubMed ID: 30536734
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype.
    Takada K, Toyokawa G, Kinoshita F, Jogo T, Kohashi K, Wakasu S, Ono Y, Tanaka K, Oba T, Osoegawa A, Tagawa T, Azuma K, Okamoto I, Shimokawa M, Oda Y, Mori M.
    J Cancer Res Clin Oncol; 2020 Oct 20; 146(10):2639-2650. PubMed ID: 32405745
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.
    He Y, Yu H, Rozeboom L, Rivard CJ, Ellison K, Dziadziuszko R, Suda K, Ren S, Wu C, Hou L, Zhou C, Hirsch FR.
    J Thorac Oncol; 2017 May 20; 12(5):814-823. PubMed ID: 28132868
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
    Handa Y, Tsutani Y, Shiroma N, Kai Y, Mimae T, Miyata Y, Takeshima Y, Arihiro K, Okada M.
    Clin Lung Cancer; 2020 Jul 20; 21(4):e302-e314. PubMed ID: 32102750
    [Abstract] [Full Text] [Related]

  • 12. PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy.
    Chen K, Cheng G, Zhang F, Zhu G, Xu Y, Yu X, Huang Z, Fan Y.
    Lung Cancer; 2020 Apr 20; 142():98-105. PubMed ID: 32120230
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression.
    Cai Y, Wu H, Shi X, Dong Y, Chang X, Zhang L, Zhou L, Su D, Yang M.
    BMC Cancer; 2020 Feb 24; 20(1):148. PubMed ID: 32093629
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of immune checkpoint inhibitors according to PD-L1 tumor proportion scores in non-small cell lung cancer.
    Park S, Choi YD, Kim J, Kho BG, Park CK, Oh IJ, Kim YC.
    Thorac Cancer; 2020 Feb 24; 11(2):408-414. PubMed ID: 31841269
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological characteristics and tumor infiltrating immune cells associations of PD-L1 tumor expression in non-small cell lung cancer patients.
    Aazzane O, Bakhtaoui FZ, Stitou S, Fellah H, Karkouri M.
    Tunis Med; 2024 Apr 05; 102(4):223-228. PubMed ID: 38746962
    [Abstract] [Full Text] [Related]

  • 20. Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
    Driver BR, Miller RA, Miller T, Deavers M, Gorman B, Mody D, Ge Y, Barrios R, Bernicker E, Kim M, Cagle PT.
    Arch Pathol Lab Med; 2017 Nov 05; 141(11):1529-1532. PubMed ID: 28829153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.